PACTR202111860919273尚未招募未知
Feasibility and accuracy of nanosensor-based breast cancer diagnosis at the point-of-care-AIKILI technology
Aikili Biosystems Inc.0 个研究点目标入组 40 人开始时间: 2021年10月27日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 19 Year(s) 至 44 Year(s)（—）
- 性别
- Female
入选标准
- •Adult female patients with known or suspected breast malignancy being referred for biopsy of the suspicious lesion.
- •Women with metastatic breast cancer and who will undergo treatment in the subsequent 2 weeks for recurrent disease with either cytotoxic and/or targeted therapies.
- •Women with metastatic breast cancer with any prior chemotherapy regimen or never treated allowed.
- •Women with metastatic breast cancer who must be able to understand and sign an informed consent.
排除标准
- •Children defined as patients under 18 years of age
- •Patients not pursuing cancer treatment / monitoring at Aga Khan University Hospital
研究者
相似试验
已完成
1 期
Effects of pumpkin (Cucurbita ficifolia Bouché) in lipid and glycemic profile of type 2 diabetics individuals: a randomized double blinded clinical trialTest of tolerance to abnormal glucose and insulin-dependent diabetes mellitus.R73.0RBR-7b5hhkEmbrapa Hortaliças
尚未招募
Unknown
The evaluation of a novel biosensor to continuously monitor human fetal scalp lactate intrapartumACTRN12624000925549VitalTrace Pty Ltd20
已完成
不适用
Feasibility and Accuracy of Nanosensor-based Cancer Diagnosis at the Point-of-care (Chedza)Breast NeoplasmsLymphomaNCT04119154Harvard School of Public Health (HSPH)270
尚未招募
不适用
Development and evaluation of flexible sensor devices and construction of plasmid positive controls for molecular diagnosis and detection of residual disease in Leukemiaymphoblastic LeukemiaC95.9RBR-10t3wc7zInstituto Aggeu Magalhães - Fiocruz de Pernambuco
进行中（未招募）
Unknown
anoNeedle evaluation studyISRCTN11167914Hampshire Hospitals NHS Foundation Trust20